Abstract
This study compared the sensitivity and tolerability of antipsychotics in patients with bipolar disorder or schizophrenia. English-language literature from January 1966 to December 2006 cited in MEDLINE was searched for the terms antipsychotics, typical antipsychotics, atypical antipsychotic, generic and brand names of antipsychotics, safety, tolerability, discontinuation due to adverse events, somnolence, and bipolar mania, bipolar depression, bipolar disorder, manic-depressive illness, or schizophrenia, randomized, double blind, and controlled clinical trial. Randomized, double-blind, placebo-controlled, monotherapy studies of anti-psychotics in both bipolar disorder and schizophrenia were prioritized. Absolute risk increase (ARI) or reduction (ARR) and the numbers needed to treat to harm (NNTH) or benefit (NNTB) for the discontinuation due to adverse events and somnolence relative to placebo were estimated. Ten acute trials in mania, 3 in bipolar depression, and 8 in schizophrenia were identified, along with 2 maintenance studies in bipolar disorder and 2 in schizophrenia. In schizophrenia, ziprasidone caused significantly more discontinuations due to adverse events than placebo, with an NNTH of 19, while aripiprazole caused...Continue Reading
Citations
Nov 13, 2009·European Archives of Psychiatry and Clinical Neuroscience·Stefan KlingbergWolfgang Wölwer
Aug 12, 2009·The Australian and New Zealand Journal of Psychiatry·Jae Seung ChangYong Sik Kim
Nov 16, 2012·Neuropsychiatric Disease and Treatment·Nizar El-Khalili
Feb 3, 2012·CNS Drugs·Elena P Calandre, Fernando Rico-Villademoros
Nov 3, 2010·The Journal of Clinical Psychiatry·Keming GaoJoseph R Calabrese
May 13, 2014·Journal of Neural Transmission·Susanna WatersNicholas Waters
Aug 14, 2009·Expert Review of Neurotherapeutics·Keming GaoJoseph R Calabrese
Nov 6, 2008·Expert Opinion on Drug Safety·Joshua T Kantrowitz, Leslie Citrome
Apr 10, 2010·Perspectives in Psychiatric Care·Marilyn A DaviesKathryn Puskar
May 31, 2015·Neuroscience Bulletin·Keming GaoJoseph R Calabrese
Jan 30, 2013·Expert Opinion on Pharmacotherapy·Andrea FagioliniFrancesco Casamassima
Sep 30, 2010·The International Journal of Neuropsychopharmacology·Zuowei WangKeming Gao
Oct 10, 2013·The International Journal of Neuropsychopharmacology·E M van der ZwaalR A H Adan
Jul 4, 2016·CNS Drugs·Fang FangKeming Gao
Dec 23, 2016·Expert Review of Neurotherapeutics·Fang FangKeming Gao
Aug 14, 2010·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Elliott Kyung Lee, Alan B Douglass
Feb 4, 2016·Journal of Psychopharmacology·Nir BarakJoseph H Albeck
Jun 2, 2012·Journal of Psychopharmacology·Julie Eve DesmaraisHoward C Margolese
Aug 3, 2018·Psychopharmacology·Mitsukuni MurasakiShinya Kamei
Apr 2, 2019·Journal of Clinical Psychopharmacology·Keming GaoJoseph R Calabrese
Feb 13, 2010·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Heinz GrunzeUNKNOWN WFSBP Task Force On Treatment Guidelines For Bipolar Disorders
Jun 18, 2019·Expert Opinion on Drug Safety·Yuanhan BaiKeming Gao
Apr 9, 2013·Pharmacological Reports : PR·Piotr RatajczakElżbieta Nowakowska
Apr 24, 2013·Journal of Clinical Psychopharmacology·Keming GaoJoseph R Calabrese
Mar 29, 2019·Pteridines·Celine C CoronaTeodor T Postolache
Mar 7, 2020·Journal of Clinical Psychopharmacology·Yuanhan BaiKeming Gao
Nov 3, 2016·Journal of Clinical Psychopharmacology·Keming GaoJoseph R Calabrese
Aug 14, 2012·MMW Fortschritte der Medizin·Florian SeemüllerHans-Jürgen Möller
Jul 19, 2017·Expert Opinion on Drug Discovery·Awais Aftab, Keming Gao
Aug 15, 2017·Frontiers in Neuroscience·Zachary FreybergJacob S Ballon
Oct 22, 2015·Journal of Clinical Psychopharmacology·Christopher J MillerMark S Bauer
Jan 8, 2021·Journal of Psychopharmacology·Gabriella NyitraiAndrás Czurkó
Nov 2, 2019·Journal of Affective Disorders·Yuanhan BaiKeming Gao
Dec 29, 2020·Pharmacopsychiatry·Hideo KatoHiroyuki Uchida
Jun 20, 2020·Bipolar Disorders·Hitoshi SakuraiUNKNOWN Medical Education Panel of the Japanese Society of Clinical Neuropsychopharmacology
Dec 20, 2011·Clinical Therapeutics·Renrong WuKeming Gao
Oct 11, 2017·Progress in Neuro-psychopharmacology & Biological Psychiatry·Ronald KimKathryn J Reissner
May 11, 2021·Journal of Psychiatric Research·Rui DongXiang Yang Zhang
Jun 1, 2021·Psychiatry Research·Jian ZhangKeming Gao
Aug 10, 2021·Substance Use & Misuse·Renata AlisauskieneElse-Marie Løberg